International patient stories after the NMC rules: what hospitals can still publish

Last reviewed 2 November 2026

Since 6 October 2026, the NMC’s advertising guidelines bar doctors and hospitals in India from using patient testimonials, success stories and promotional case studies, even with the patient’s consent. That includes stories from international patients. What a hospital can still publish for source markets is doctor-led explanation of the process, anonymised case material used for genuine education, and the people and logistics behind the journey. Consent discipline still matters for anything that features a patient, and every existing story needs auditing now.

Quick summary in 6 slides (swipe)

←→Download the carousel (PDF)

At a glance

For years the most persuasive thing a hospital could show a family in another country was another family from the same country who had been through it. Nothing a marketing team wrote competed with that. International patient stories became the centrepiece of medical value travel marketing, and they were also the part with the loosest rules.

That chapter is over for hospitals and doctors in India. The NMC’s guidelines of 6 October 2026 treat patient testimonials and success stories as promotion and bar them, and patient consent does not change that. A story filmed in Hyderabad and shown to families in Dhaka, Muscat or Nairobi is still the hospital’s advertising. The question for international marketing teams is no longer how to take consent properly. It is what to publish instead, and what to do with the stories already out there.

What changed on 6 October 2026

The NMC’s Ethics and Medical Registration Board issued Guidelines on Ethical Advertising and Public Communication for hospitals, medical institutions and registered medical practitioners, in force immediately. For patient stories, the parts that matter are these:

• No requesting or sharing patient testimonials or reviews for promotion, even with the patient’s consent.
• No success stories, promotional case studies or before-and-after images. Anonymised case material used for genuine scientific or educational purposes is the exception.
• No AI-generated patients, voices or testimonials, and promotional content made with AI must be labelled.
• No outcome, superiority or guaranteed-result claims, which most patient stories carried by implication.
• Penalties run from a warning and ethics training to suspension of registration, and up to removal from the register for repeated violations.

Two points catch international teams out. First, the rules follow the doctor and the hospital, not the audience, so content made for a source market is covered. Second, many destination and source countries have their own rules on health advertising and personal data, so the stricter of the two usually decides. Check both with your legal team before acting on a specific case.

Why international stories were always the riskiest kind

The new rules settle a problem that was there all along. A story about illness is information about a person that they did not otherwise choose to publish. In a large Indian city, a testimonial disappears into the noise. Sent back into a source market, it does the opposite. Source communities are often small, closely connected and attentive to who went abroad for treatment and why, so a face, a first name and a city is identification, not anonymity.

The consequences landed on the family, not the hospital: their standing, their work, what an employer or insurer believed, how their children were treated at school. Distance meant they could not easily ask for a change, and subtitled clips reposted by strangers meant the hospital could only ever control its own channels. Many of the stories now being retired were taken on discharge day, in a language the family half read, by someone they felt unable to refuse.

This connects directly to The compliance line in international patient marketing, Medical visas and entry rules and International patient enquiries.

What hospitals can still publish for source markets

The trust a patient story used to create has to come from somewhere else now. These formats do that work within the rules:

The work on social and video for source markets covers how to produce and distribute these formats, and country landing pages covers where they sit. Both now assume no patient testimonials.

Retire what is already published

Most hospitals with an international programme have a library of patient stories spread across the website, social accounts, YouTube, brochures, facilitator decks and old advertising. That library is now a compliance liability. Work through it in this order:

• List everything. Every patient video, quote, photo and written story on channels you control, including pinned posts, highlights, playlists and landing pages.
• Stop paid use first. Pause any advertising, boosted posts or sponsored placements using patient content the same day.
• Take it down or make it private. Remove or unlist the material from your website and accounts. Keep an internal record of what was removed and when.
• Tell the families who asked for it. Where a family featured in a story, a short message in their language saying the material has been taken down is a courtesy that costs little.
• Chase third parties. Ask facilitators, agents and partners to remove patient material that promotes your hospital. You cannot recall reshared copies, but you can stop supplying them.
• Delete raw footage you no longer have a reason or permission to hold.

When a patient features in educational content

Anonymised case material for genuine scientific or educational use remains possible. Where any patient detail is involved, the consent discipline international teams built over the years still applies, and arguably matters more:

• Separate from treatment. Consent on its own document, never bundled with treatment or discharge paperwork, and never sought while a bill, estimate or concession is pending.
• In the family’s language. A plain-language document in the language they read, explained by a planned interpreter rather than a relative or the coordinator handling the case.
• A recorded read-back. The family says in their own words what they agreed to, and the file records the language and the interpreter.
• The right asker. Not the treating doctor, not the person who handled billing, and not anyone with a target for collecting cases.
• Real withdrawal. A named person, a number and a channel the family already uses, printed on their copy, with a stated turnaround and no questions asked.

India’s data protection rules point the same way, with consent that is specific, informed and withdrawable. That thinking is covered in consent under DPDP, and language cover belongs in interpreters as a service, not a favour.

Children

Do not publish anything that identifies a child, in any format. A guardian’s permission is not the same as the patient’s, and a child lives with the material for decades without having had any say in it. Under the new rules there is no promotional use for it anyway.

Patients who post on their own

Grateful families will still post about their treatment, tag the hospital and send thank-you videos. That is their right. What changes is the hospital’s response: do not reshare, repost, pin or quote the content, do not ask families to post, and do not offer anything in return for a post. A private thank-you message is fine. If a family asks a clinical question in a comment, move it to a consultation rather than answering in public.

Facilitators, agents and partners

Facilitators often use hospital patient stories in their own marketing. Your name is on that content either way. Add a clause to every facilitator agreement that bars patient testimonials, success stories and before-and-after material promoting your hospital, and check periodically what is actually being circulated in each market.

Where to start this quarter

• This week: pause paid use of any patient content and start the inventory across website, social accounts, video channels and partner materials.
• This month: take down or unlist every patient testimonial and success story, and write to facilitators asking them to do the same.
• This quarter: replace the gap with doctor-led explainers and journey content for your two largest source markets, subtitled in their languages.
• Ongoing: a one-page house standard on patient content, signed off by the medical director and legal, and a quarterly check that nothing has crept back.

Trust is the whole proposition a hospital sells across a border. The stories that used to carry it were always borrowed from families who bore the risk. Building it instead from visible expertise and a process families can see is slower, but it is the version that holds up. That is why it belongs inside the funnel discipline described in the international patient funnel is a digital product.

Further reading from primary sources

• What hospital ads can and cannot say: NMC 2026 guidelines and ASCI rules: the full summary of the 6 October 2026 guidelines, with sources and penalties.
• DPDP Rules, 2025 (Press Information Bureau): India’s notified data protection rules and timeline.
• National Medical Commission: check the official notice for exact wording before acting on a specific case.
• Government of India: e-Visa (including e-Medical and e-Medical Attendant visas): the official source families should check for visa rules.

Questions people ask